Tumoricidal Activity of RNase A and DNase I

Cover Page

Cite item

Full Text

Abstract

In our work the antitumor and antimetastatic activities of RNase A and DNase I were studied using two murine models of pulmonary (Lewis lung carcinoma) and liver (hepatoma A-1) metastases. We found that intramuscular administration of RNase A at the dose range of 0.1-50 μg/kg retarded the primary tumor growth by 20-40%, and this effect disappeared with the increase in RNase A dose over 0.5 mg/kg. DNase I showed no effect on the primary tumor growth. The intramuscular administration of RNase A (0.35-7 μg/kg) or DNase I (0.02-2.3 mg/kg) resulted in a considerable decrease in the metastasis number into the lungs of animals with Lewis lung carcinoma and a decrease of the hepatic index of animals with hepatoma 1A. A histological analysis of the organs occupied by metastases revealed that the administration of RNase A and DNase I induced metastasis pathomorphism as manifested by the destruction of oncocytes, an increase in necrosis and apoptosis foci in metastases, and mononuclear infiltration. Our data indicated that RNase A and DNase I are highly promising as supplementary therapeutics for the treatment of metastasizing tumors.

Full Text

Tumoricidal Activity of RNase A and DNase I
×

About the authors

O A Patutina

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

N L Mironova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

E I Ryabchikova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

N A Popova

Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

V P Nikolin

Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

V I Kaledin

Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

V V Vlassov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

M A Zenkova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: marzen@niboch.nsc.ru

References

  1. Dalmay T., Edwards D.R. // Oncogene. 2006. V. 25. no. 46. P. 6170-6175.
  2. Ardelt B., Ardelt W., Darzynkiewicz Z. // Cell Cycle. 2003. V. 2. no. 1. P. 22-24.
  3. Iorio M.V., Ferracin M., Liu C.G. et al. // Cancer Res. 2005. V. 65. no. 16. P. 7065-7070.
  4. Garcia-Olmo D., Garcia-Olmo D.C., Ontanon J. et al. // Blood. 2000. V. 95. no. 2. P. 724-735.
  5. Kotchetkov R., Cinatl J., Krivtchik A.A. et al. // Anticancer Res. 2001. V. 21. P. 1035-1042.
  6. Soucek J., Pouckova P., Matousek J. et al. // Neoplasma. 1996. V.43. no. 5. P. 335-340.
  7. Cinatl J.Jr., Cinatl J., Kotchetkov R. et al. // Int. J. Oncol. 1999. V. 15. no. 5. P. 1001-1009.
  8. Pouckova P., Zadinova M., Hlouskova D. et al. // J. Control Release. 2004. V. 95. no. 1. P. 83-92.
  9. Rybak S.M., Pearson J.W., Fogler W.E. et al. // J. Natl. Cancer Inst. 1996. V. 88. no. 11. P. 747-753.
  10. Lee I., Lee Y.H., Mikulski S.M. // J. Surg. Oncol 2000. V. 73. no. 3. P. 164-171.
  11. Costanzi J., Sidranski D., Navon A. et al. // Cancer Invest. 2005. V. 23. no. 7. P. 643-650.
  12. Ledoux L. // Nature. 1955. V. 175. no. 4449. P. 258-259.
  13. Ledoux L. // Nature. 1955. V. 176. no. 4470. P. 36-37.
  14. De Lamirande G. // Nature. 1961. V. 192. P. 52-54.
  15. Roth J.S. // Cancer Res. 1963. V. 23. P. 657-666.
  16. Klink T.A., Raines R.T. // J. Biol. Chem. 2000. V. 275. P. 17463-17467.
  17. Leland P.A., Schultz L.W., Kim B.M., Raines R.T. // Pro. Natl. Acad. Sci. USA. 1998. V. P. 10407-10412.
  18. Rutkoski T.J., Raines R.T. // Curr. Pharm. Biotechnol. 2008. V. 9. no. 3. P. 185-189.
  19. Wu Y., Mikulski S.M., Ardelt W. et al. // J. Biol Chem. 1993. V. 268. no. 14. P. 10686-10693.
  20. Kim J.S., Soucek J., Matousek J., Raines R.T. // J. Biol. Chem. 1995. V. 270. no. 18. P. 10525-10530.
  21. Sugihara S., Yamamoto T., Tanaka H. et al. // Br. J. Cancer. 1993. V. 67. P. 66-70.
  22. Tokita K., Sugihara S., Hiraoka T. et al. // Invasion Metastasis. 1995. V. 15. P. 46-59.
  23. Silberklang M., Gillum A.M., RhajBhandary // Methods Enzymol. 1979. V. 59. P. 58-109.
  24. Tomayko M.M., Reynolds C.P. // Cancer Chemother. Pharmacol. 1989. V. 24. P. 148-154.
  25. Klink T.A., Raines R.T. // Biol. Chem. 2000. V. 275. P. 17463-17467.
  26. Kim J.S., Soucek J., Matousek J. et al. // J. Biol. Chem. 1995. V. 270. P. 31097-31102.
  27. Matousek J. // Comp. Biochem. Physiol. C. 2001. V. 129. P. 175-191.
  28. Haigis M.C., Raines R.T. // J. Cell Sci. 2003. V. 116. P. 313-324.
  29. Zhao H., Ardelt B., Ardelt W. et al. // Cell Cycle. 2008. V. 7. P. 3258-3261.
  30. Sorrentino S., Naddeo M., Russo A. et al. // Biochemistry. 2003. V. 42. P. 10182-10190.
  31. Blaszczyk J., Gan J., Tropea J.E. et al. // Structure. 2004. V. 12. P. 457-466.
  32. Kojima K. // Nagoya J. Med. Sci. 1993. V. 56. P. 1-18.
  33. Ran S., Downes A., Thorpe P.E. // Cancer Res. 2002. V. 62. P. 6132-6140.
  34. Ilinskaya O.N., Dreyer F., Mitkevich V.A. et al. // Protein Sci. 2002. V. 11. P. 2522-2525.
  35. Ilinskaya O.N., Koschinski A., Mitkevich V.A. et al. // Biochem. Biophys. Res. Commun. 2004. V. 314. P. 550-554.
  36. Zhang B., Pan X., Cobb G.P. et al. // Dev. Biol. 2007. V. 302. P. 1-12.
  37. Wong T.S., Liu X.B., Wong B.Y. et al. // Clin. Cancer Res. 2008. V. 14. P. 2588-2592.
  38. Garzon R., Fabbri M., Cimmino A. et al. // Trends Mol. Med. 2006. V. 12. no. 12. P. 580587.
  39. Zhang B., Pan X., Cobb G. P. et al. // Dev. Biol. 2007. V. 302. no. 1. P. 1-12.
  40. Iorio M.V., Ferracin M., Liu C.G. et al. // Cancer Res. 2005. V. 65. no. 16. P. 7065-7070.
  41. Wong T.S., Liu X.B., Wong B.Y. et al. // Clin. Cancer Res. 2008. V. 14. no. 9. P. 2588-2592.
  42. Fauve R.M. // In: Azuma I., JollÈs G. (ed) Immunostimulants: Now and Tomorrow. 1987. Springer-Verlag, Berlin, pp.225-234.
  43. Januaz M., Wieczorek Z., Spiegel K. et al. // Mol. Immunol. 1987. V. 249. no. 10. P. 1029-1031.
  44. Vanhoof G., Goosens F., De Meester I. et al. // The FASEB Journal. 1995. V. 9. P. 736-744.

Copyright (c) 2010 Patutina O.A., Mironova N.L., Ryabchikova E.I., Popova N.A., Nikolin V.P., Kaledin V.I., Vlassov V.V., Zenkova M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies